SCHEMBL10286338

SCHEMBL10286338

CCOc1ccc2c(n1)C(O)CCC2

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
POLB P06746 1/20 0.34
TDP1 Q9NUW8 1/20 0.34
KMT2A Q03164 2/20 0.33
ACHE P22303 1/20 0.33
MEN1 O00255 1/20 0.33
IDH1 O75874 1/20 0.33
MAPK8 P45983 1/20 0.33
MAPT P10636 1/20 0.33
HDAC8 Q9BY41 1/20 0.32
CXCR4 P61073 1/20 0.32
P2RX7 Q99572 2/20 0.31
KDM4E B2RXH2 1/20 0.31
NPC1 O15118 1/20 0.31
CASP3 P42574 1/20 0.31
RAB9A P51151 1/20 0.31
SENP8 Q96LD8 1/20 0.31
SENP7 Q9BQF6 1/20 0.31
SENP6 Q9GZR1 1/20 0.31
DRD2 P14416 1/20 0.31
DRD3 P35462 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10286321 0.83 HTR2C (0.39) POLBTDP1ACHEDRD2DRD3
SCHEMBL10287016 0.77 ACHE (0.38) ACHECXCR4NPC1RAB9AKCNH2
SCHEMBL10286376 0.75 ACHE (0.41) ACHEHDAC8KCNH2ALDH1A1
SCHEMBL10286342 0.75 UGT2B17 (0.42) POLBACHEHDAC8
SCHEMBL14884981 0.74 ACHE (0.38) ACHECXCR4KDM4ERAB9ADRD2
SCHEMBL10287319 0.74 ACHE (0.38) ACHECXCR4KDM4ERAB9ADRD2
SCHEMBL5111399 0.74 ACHE (0.38) ACHECXCR4KDM4ERAB9ADRD2
SCHEMBL10286332 0.74 ACHE (0.37) POLBKMT2AACHEMEN1KDM4E
SCHEMBL10286340 0.73 ACHE (0.39) POLBKMT2AACHEMEN1MAPT
SCHEMBL10286300 0.73 ACHE (0.35) ACHENPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20130102631-A1 NOVEL MICROBIOCIDAL DIOXIME ETHER DERIVATIVES SYNGENTA CROP PROTECTION LLC (US) 2013-04-25 US disclosed
WO-2012001040-A1 NOVEL MICROBIOCIDAL DIOXIME ETHER DERIVATIVES SYNGENTA PARTICIPATIONS AG (CH) 2012-01-05 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130102631-A1 NOVEL MICROBIOCIDAL DIOXIME ETHER DERIVATIVES MSR1, DDT, MPO POLB 1449/4885TDP1 841/4885KMT2A 1808/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.